Pathogenic bacterial growth at wound sites, particularly Staphylococcus aureus, poses a serious threat during trauma. Delayed treatment can lead to increased inflammation and severe tissue damage. In this study, a chitosan cross-linked polycationic peptide-conjugated graphene-silver (CGrAP) nanocomposite hydrogel film was developed as an antibacterial wound dressing to treat S. aureus infections. The CGrAP hydrogel was synthesized via a Schiff-base reaction between the epsilon-poly-l-lysine functionalized graphene-silver nanocomposite and chitosan, and then cast into a film. Its antibacterial action is due to electrostatic interactions and ROS generation, finally disrupting the bacterial cells. In vivo studies on Wistar rat model demonstrated superior bacterial eradication and wound healing compared to antibiotic treatment. The CGrAP hydrogel also showed excellent physicochemical properties, including porosity, water uptake and cytocompatibility with L929 fibroblast cells along with no skin irritation or acute dermal toxicity. These results suggest that, CGrAP nanocomposite hydrogel films have strong potential for antibacterial wound dressing development in chronic wound care.

Chitosan-based hydrogels have been utilized over the years as an efficient hemorrhage because of their biocompatibility and biodegradability nature. Here we have nanoengineered the polycationic peptide-conjugated graphene‑silver nanocomposite into the chitosan matrix as a 3D highly porous CGrSP scaffold to facilitate rapid hemostasis and prevent bacterial infection. This CGrSP scaffold interacted with blood cells and platelets, initiating the blood coagulation process by activating the plasmatic contact system. Notably, it reduced the activated Partial Thromboplastin Time (aPTT) and Prothrombin Time (PT), indicating that the scaffold promoted platelet activation associated with Factors XII and X, leading to fibrin formation and clot stabilization. In vitro studies showed that the CGrSP scaffold reduced whole blood clotting time by 87 % compared to the commercial dressing "QuikClot." Additionally, in vivo studies using rat-tail amputation and skin laceration models demonstrated a significant reduction in hemostatic time compared to both the chitosan scaffold (p-value<0.003) and "QuikClot" (p-value<0.01). Beyond its hemostatic properties, the CGrSP scaffold exhibited strong antibacterial activity, achieving a 5-log reduction against both Escherichia coli and Staphylococcus aureus. With its biodegradable nature, rapid hemostasis, and potential for tissue regeneration, the CGrSP scaffold presents a novel and safe therapeutic material.

Bacterial infections caused by Staphylococcus aureus are one of the growing concerns for human health care management globally. Antibiotic-associated adverse effects and the emergence of bacterial resistant strains necessitate the development of an alternative yet effective approach. Nanoemulsion-based therapy has emerged as a potential therapeutic strategy to combat bacterial infestation. Herein, we designed a cationic metal nanoparticle-conjugated fusogenic nanoemulsion (CFusoN) as a lipid solubilizing nanovesicle for the effective treatment of S. aureus infection with a killing efficiency of 99.999%. The cationic nanoparticle-conjugated nanoemulsion (viz. NECNP) (24.4 ± 2.9 mV) electrostatically bound with the negatively charged bacterial cell membrane (-10.2 ± 3.7 mV) causing alteration of the bacterial surface charge. The fluorometric and flow cytometry studies confirmed the bacterial membrane depolarization and altered cell membrane permeability leading to cell death. The atomic force microscopic studies further demonstrated the damage of the cellular ultrastructure, while the transmission electron microscopic image and membrane lipid solubilization analysis depicted the solubilization of the bacterial membrane lipid bilayer along with the leakage of the intracellular contents. The cell membrane fatty acid analysis revealed that the methyl esters of palmitic acid, stearic acid and octadecadienoic acid isomers were solubilized after the treatment of S. aureus with CFusoN. The bactericidal killing efficiency of CFusoN is proposed to occur through the synergistic efficacy of the targeted attachment of CNP to the bacterial cells along with the lipid solubilization property of NE. Interestingly, NECNP didn't elicit any in vitro hemolytic activity or cytotoxicity against red blood cells (RBCs) and L929 fibroblast cells, respectively, at its bactericidal concentration. Furthermore, a porcine skin wound infection model exhibited the enhanced wound cleansing potency of CFusoN in comparison to the commercially available wound cleansers. The obtained antibacterial activity, biocompatibility and skin wound disinfection efficacy of the NECNP demonstrated the formulation of a cell targeted CFusoN as a promising translatable strategy to combat bacterial infection.

Biofilm-associated wound infection is principally perceived as the bacterial defense mechanism that hinders antibiotic penetration, causes toxin impairment, and suppresses the immunological responses of the host immune system. Several antibiofilm agents have been developed, but the least of these agents can simultaneously cornerstone on the biofilm-associated immunosuppression and bacterial toxin-induced cellular dysfunction. Inspired by the fusogenic property of nanodroplets and immunomodulatory functions of metal nanoparticles, biofilm targeted anti-virulent immunomodulatory cationic nanoparticle shelled nanodroplets (C-AgND) is fabricated to completely disintegrate and eradicate the Staphylococcus aureus (S. aureus) biofilm. The specific binding of C-AgND neutralizes the negatively charged EPS layer, causing their destabilization followed by penetration of the nanoformulation into the biofilm matrix, killing the persister cells. Consequently, C-AgND eliminates the virulence property of the S. aureus biofilm through α-hemolysin neutralization. C-AgND promotes a strong immunomodulatory effect by polarizing macrophages into their M1 phenotype to induce phagocytosis of the disintegrated biofilm-released residual cells, rejuvenating the host's innate immune responses for the complete eradication of the biofilm. Moreover, the ex vivo skin wound infection model illustrates an excellent biofilm eradication efficacy of C-AgND in comparison to the commercial ones, rendering them to be a promising replacement of existing antibiofilm agents in clinical application.

In these studies, we designed and investigated the potential anticancer activity of five iron(II) cyclopentadienyl complexes bearing different phosphine and phosphite ligands. All complexes were characterized with spectroscopic analysis viz. NMR, FT–IR, ESI–MS, UV–Vis, fluorescence, XRD (for four complexes) and elemental analyses. For biological studies, we used three types of cells—normal peripheral blood mononuclear (PBM) cells, leukemic HL-60 cells and non-small-cell lung cancer A549 cells. We evaluated cell viability and DNA damage after cell incubation with these complexes. We observed that all iron(II) complexes were more cytotoxic for HL-60 cells than for A549 cells. The complex CpFe(CO)(P(OPh)3)(η1-N-maleimidato) 3b was the most cytotoxic with IC50 = 9.09 µM in HL-60 cells, IC50 = 19.16 µM in A549 and IC50 = 5.80 µM in PBM cells. The complex CpFe(CO)(P(Fu)3)(η1-N-maleimidato) 2b was cytotoxic only for both cancer cell lines, with IC50 = 10.03 µM in HL-60 cells and IC50 = 73.54 µM in A549 cells. We also found the genotoxic potential of the complex 2b in both types of cancer cells. However, the complex CpFe(CO)2(η1-N-maleimidato) 1 which we studied previously, was much more genotoxic than complex 2b, especially for A549 cells. The plasmid relaxation assay showed that iron(II) complexes do not induce strand breaks in fully paired ds-DNA. The DNA titration experiment showed no intercalation of complex 2b into DNA. Molecular docking revealed however that complexes CpFe(CO)(PPh3) (η1-N-maleimidato) 2a, 2b, 3b and CpFe(CO)(P(OiPr)3)(η1-N-maleimidato) 3c have the greatest potential to bind to mismatched DNA. Our studies demonstrated that the iron(II) complex 1 and 2b are the most interesting compounds in terms of selective cytotoxic action against cancer cells. However, the cellular mechanism of their anticancer activity requires further research.

Wound dressing with poor antibacterial properties, the tendency to adhere to the wound site, poor mechanical strength, and lack of porosity and flexibility are the major cause of blood loss, delayed wound repair, and sometimes causes death during the trauma or injury. In such cases, hydrogel-based antibacterial wound dressing would be a boon to the existing dressing as the moist environment will maintain the cooling temperate and proper exchange of atmosphere around the wound. In the present study, the multifunctional graphene with silver and ε-Poly-l-lysine reinforced into the chitosan matrix (CGAPL) was prepared as a nanobiocomposite wound dressing. The contact angle measurement depicted the hydrophilic property of CGAPL nanobiocomposite dressing (water contact angle 42°), while the mechanical property was 78.9 MPa. The antibacterial and cell infiltration study showed the antimicrobial property of CGAPL nanobiocomposite wound dressing. It also demonstrated no cytotoxicity to the L929 fibroblast cells. Chorioallantoic Membrane (CAM) assay showed the pro-angiogenic potential of CGAPL nanobiocomposite wound dressing. In-vitro scratch wound assay confirmed the migration of cells and increased cell adhesion and proliferation within 18 h of culture on the surface of CGAPL nanobiocomposite dressing. Later, the in-vivo study in the Wistar rat model showed that CGAPL nanobiocomposite dressing significantly enhanced the wound healing process as compared to the commercially available wound dressing Tegaderm (p-value <0.01) and Fibroheal@Ag (p-value <0.005) and obtained complete wound closure in 14 days. Histology study further confirmed the complete healing process, re-epithelization, and thick epidermis tissue formation. The proposed CGAPL nanobiocomposite wound dressing thus offers a novel wound dressing material with an efficient and faster wound healing property.

Fabrication of Janus type asymmetric wettable aerogel with high mechanical strength and antifouling property remains a great challenge for effective oil/water separation. Herein, inspired by the lotus leaf structure, we reported eco-benign fabrication of stearic acid coated biomaterial functionalized porous network structure of graphene oxide (GCCS) nanobioaerogel with Janus wettability (water contact angle: 129.4 +/- 10.1 degrees at top side and 40.35 +/- 2.4 degrees at bottom side), excellent modulus of elasticity (4.74 kPa), and antibiofouling properties. FTIR results revealed that the covalent, electrostatic, hydrophobic, and 7C-7C interactions of graphene oxide (GO) and biomaterials provided high mechanical strength to the GCCS nanobioaerogel. The bifunctional GCCS nanobioaerogel with 50% hydrophobic coating exhibited excellent water floating and anti-overturning behaviour under high waves. Moreover, this asymmetric aerogel simultaneously removed oil through top side and water soluble dyes through bottom of the aerogel at the oil/water interface. The bifunctional GCCS nanobioaerogel exhibited high oil removal capacity and removed 227.53 +/- 9.35 g/g of oil due to high surface area and porous structure. At the same time dye adsorption capacity of the GCCS nanobioaerogel was calculated as 204.17 +/- 7.49 mg/g at optimum pH = 4.0, 60 degrees C in both single and multi-component system. In addition, the nanobioaerogel exhibited excellent bactericidal activity (99.999%) along with antibiofouling property and effectively disinfect the bacteria contaminated water. Moreover, the dyes and oils were easily eluted from GCCS nanobioaerogel and recycled multiple times. Thus, this manuscript highlights the potential use of renewable natural biomaterial to fabricate biomimetic porous aerogel material with asymmetric wettability, high mechanical strength and antifouling properties for efficient removal of oil, dyes and microbial pathogens.

Fabrication of mechanically stable porous materials with excellent adsorption capacity for different types of heavy metal ions simultaneously is still scientifically and technically challenging. Herein, the Response Surface Methodology (RSM) was employed to statistically fabricate the biological materials (collagen, chitosan) functionalized graphene-magnetite (BGM) hybrid nanobioaerogel. RSM statistically predicted the concentration of GO, Fe2+, collagen-chitosan mixture and glutaraldehyde as 6.78 mg/mL, 0.20 M, 61.39 mg/mL and 68.63 mu M, respectively, for the maximum responses of Young's modulus (5.26 kPa) and adsorption capacity. Various spectroscopic and microscopic techniques demonstrated the porous interconnected network structure and superparamagnetic behavior of BGM hybrid nanobioaerogel with a saturation magnetization value of 19.34 emu/g. The nanobioaerogel exhibited fast and high adsorption for Cu(II) (183.96 +/- 5.68 mg/g, 29 min), Cd(II) (67.04 +/- 1.53 mg/g, 36 min), Cr(VI) (134.49 +/- 5.21 mg/g, 45 min) and As(III) (64.62 +/- 2.40 mg/g, 40 min) at optimum pH 5.0 and 60 C in multicomponent system, which is almost four times higher than commercially available activated carbon and other reported literatures. The adsorption process follows the Langmuir isotherm suggesting the monolayer chemisorption, follows pseudo-second order (Cu(II)) and intraparticle diffusion (Cd (II), Cr(VI) and As(III)) models and suggesting rate-limiting step is surface binding and internal pores. ATR-FTIR spectrum revealed that hydroxyl, amine, carboxylate, carbohydrate and iron functional groups in hybrid BGM nanobioaerogel interacted with the heavy metals in a multicomplex manner. It was easily regenerated and reused for multiple adsorptions-desorption cycles. In addition, it also showed >5 log reduction in 4 h against different pathogens and antibiofouling agents.

In these studies, we designed and investigated cyto- and genotoxic potential of five ruthenium cyclopentadienyl complexes bearing different phosphine and phosphite ligands. All of the complexes were characterized with spectroscopic analysis (NMR, FT-IR, ESI-MS, UV-vis, fluorescence and XRD (for two compounds)). For biological studies, we used three types of cells - normal peripheral blood mononuclear (PBM) cells, leukemic HL-60 cells and doxorubicin-resistance HL-60 cells (HL-60/DR). We compared the results obtained with those obtained for the complex with maleimide ligand CpRu(CO)2(η1-N-maleimidato) 1, which we had previously reported. We observed that the complexes CpRu(CO)(PPh3)(η1-N-maleimidato) 2a and CpRu(CO)(P(OEt)3)(η1-N-maleimidato) 3a were the most cytotoxic for HL-60 cells and non-cytotoxic for normal PBM cells. However, complex 1 was more cytotoxic for HL-60 cells than complexes 2a and 3a (IC50 = 6.39 μM vs. IC50 = 21.48 μM and IC50 = 12.25 μM, respectively). The complex CpRu(CO)(P(OPh)3)(η1-N-maleimidato) 3b is the most cytotoxic for HL-60/DR cells (IC50 = 104.35 μM). We found the genotoxic potential of complexes 2a and 3a only in HL-60 cells. These complexes also induced apoptosis in HL-60 cells. Docking studies showed that complexes 2a and CpRu(CO)(P(Fu)3)(η1-N-maleimidato) 2b have a small ability to degrade DNA, but they may cause a defect in DNA damage repair mechanisms leading to cell death. This hypothesis is corroborated with the results obtained in the plasmid relaxation assay in which ruthenium complexes bearing phosphine and phosphite ligands induce DNA breaks.

The resilient and adaptive nature of biofilms and its associated infections pose a serious threat in the current state of play aiming the need for a promising strategy. The two-dimensional nanomaterials functionalized with antimicrobial peptides serve as a novel approach to combat biofilms and their related infections. This review article explains the current landscape of research in this field focusing on classification and physiochemical properties of two-dimensional (2D) nanomaterials and their exploitation as antimicrobial peptide delivery system. The review also offers insights into their potential application in various settings such as medical devices wound healing and water treatment. Additionally we discuss the challenges and future directions in the development and implementation of this innovative strategy, emphasizing the need for multidisciplinary approach that bridges the gap between fundamental research and practical applications. Through a comprehensive synthesis of current literature, this review aims to provide researchers, clinicians and industry professionals with a thorough understanding of promises and challenges, which aim in the development of advanced materials and strategies for combating microbial biofilms and improving industrial control measures.

Bacterial infection by ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) pathogens are one of the major health concerns and has caused a global crisis in the healthcare sectors, leading to mortality, morbidity, and socioeconomic loss. The overuse and abuse of antibiotics has led to an increased number of MDR bacteria. Thus, conventional antibiotics have failed to show notable improvement in bacterial infections. Biofilm formations make pathogens more recalcitrant than their planktonic form, and are becoming more challenging to treat with conventional antibiotics. To overcome the challenges of the biofilm-associated chronic infections of ESKAPE pathogens, a new therapeutic strategy is urgently needed. Recently, nanomaterial-based therapies have emerged as a novel approach to combat the biofilm infection of ESKAPE pathogens. The size, shape and other physicochemical properties of nanomaterials play a significant role in targeting the biofilm and overcoming the recalcitrant bacterial infection. Herein, we give a brief review about the formation and structure of biofilms of ESKAPE pathogens and the quorum-sensing (QS) mechanism in biofilm formation. Subsequently, we discuss the conventional methods and strategies for the treatment of biofilms and their limitations. Later, we highlight different strategies for the fabrication of nanoparticles, which include solid nanoparticles, conjugated nanoparticles and nanocarrier systems that can be used to target the bacterial biofilm. We also discuss different interaction mechanisms through which nanoparticles disrupt the biofilm and kill the sessile and persister cells. Therapeutic applications of nanomaterials in biomedical fields are also systematically reviewed. Lastly, we discuss the current status and future perspectives of nanotechnology. We believe that this article provides insights into the advancement of nanotechnology, and offers an alternative therapeutic strategy to treat biofilm-associated infections.

Bacterial cellulose (BC), derived from kombucha scoby have extraordinary organoleptic properties suitable for development of leather-like materials. An improvement in physical and mechanical property is desirable for the practical applications. This work deals with the treatment of BC by incorporations of three different nanomaterials such as gold nanoparticles (AuNP), silver nanoparticles (AgNP) and graphene oxide (GO). Achieving combined benefits via synergic interactions of different nanomaterials is the major objective herein. While graphene oxide can influence some of the parameters related to mechanical properties, silver nanomaterials can offer antibacterial characteristics. Gold nano materials can bridge the BC/silver/graphene oxide as well as provide the desirable aesthetic colour. Different physical chemical and mechanical characteristics were studied in detail. For example, changes in morphology by imaging fiber network were studied using scanning electron microscopy. Fibre properties were studied by Small Angle X-Ray Scattering (SAXS) and X-Ray Diffraction (XRD). Elemental composition was studied by X-ray photoelectron spectroscopy (XPS) analysis and Raman analysis. The improvement of hydrophobicity was studied by Contact angle meter. Thermal analysis was performed using thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). A Picture was provided in ESI to show the modified material's leather-like appearances.

Targeted drug delivery has become attention in chemotherapy during the last decade. The principle of chemotherapy seeks maximum effect to the desired site and the minimum impact to other undesired sites of action. The nanoparticulated drug delivery system progressed a lot in this aspect in the last twenty years. Plant-derived natural products and their semisynthetic analogues boosted chemotherapy through their excellent mechanistic approach to killing cancer cells. Keeping in mind the available molecular targets in colorectal carcinoma (CRC), in this article, we proposed a peptide conjugated novel polymeric nanoparticle to deliver garcinol against colorectal carcinoma. Integrin binding peptide iRGD, sequence c(CRGDKGPDC), has been selected as a targeting moiety, as most CRC overexpress integrins. We encapsulated garcinol in biodegradable polymeric nanoparticle (PLGA)-conjugated with iRGD peptide on the particles' surface, and analyzed its (iRGD-GAR-NP's) in vitro and in vivo antineoplastic potential against CRC in a comparative way with gracinol (GAR) and garcinol-loaded PLGA nanoparticles (GAR-NP). In vitro cellular studies on human CRC cell lines, HCT116 and HT-29, revealed the superior cytotoxic potential of iRGD-GAR-NP over GAR and GAR-NP. The IC50 value on HCT116 cells was reduced by 2.3 times compared to GAR upon the application of iRGD-GAR-NP. At equivalent doses, iRGD-GAR-NP induced higher apoptosis in HCT116 cells and caused blockage of cell cycle at G0/G1 phase of the same. iRGD-GAR-NP increased the apoptotic population of HCT116 cells by 2.5 times compared to GAR. In vivo biodistribution study uncoiled the ability of GAR-NP and iRGD-GAR-NP to accumulate in the colons of dimethyl hydrazine-induced CRC-bearing Sprague-Dawely (SD) rats. In vivo antitumor efficacy study demonstrated the better effect of iRGD-GAR-NP to reduce CRC tumor progression in experimental animals. The survival rate of animals was also increased by 166% in the case of iRGD-GAR-NP compared to CRC-bearing animals received no treatment.

Developing new underwater glue adhesives with robust and repeatable adhesion to various surfaces is promising and useful in marine life and medical treatments. In this work, we developed a novel glue based on a copolymer with a cation-co-aromatic sequence where the cationic units contain both catechol and positively charged sites. The glue consists of a crosslinked copolymer of poly(2-hydroxy-3-phenoxypropyl acrylate-co-3-(5-(3,4 dihydroxyphenyl)-4-oxo-3 N-pentyl)imidazolium) bromide in dimethyl sulfoxide. Solidification of the glue, triggered by contact with water, undergoes a coacervation stage and causes a drastic growth of its mechanical properties over time. The glue demonstrates fast-developing, strong, and repeatable underwater adhesion to different materials and can maintain its strength for a long time. The adhesion strength tends to increase with the surface energy of the substrate material, to a maximum value of 160 kPa found in plywood. Experiments conducted in aqueous media with different pH and ionic strengths, including physiological conditions and seawater, showed an even stronger adhesion than that evolved in deionized water. Thus, the developed glue is a promising candidate for use in marine life, tissue adhesives, and other freshwater and saline water applications.

Introduction of an efficient chemodosimeter (NCD) to estimate the mutagenic hydrazine within several affected cropland flowers promptly showing ‘turn-on’ fluorescence.

Sustainable treatment of wastewater containing trivalent chromium (Cr3+) remains a significant challenge owing to the several limitations of the existing methodologies. Herein, combination of biosynthesis and Response Surface Methodology (RSM) for the fabrication and optimization of Shewanella oneidensis biofilm functionalized graphene-magnetite (GrM) nanobiocomposite was adopted as a 'living functional nanomaterial' (viz. S-GrM) for effective removal of Cr3+ ions from aqueous solution. In the biosynthetic process, S. oneidensis cells reduced the GO-akaganeite complex and adhered on the as-synthesized GrM nanocomposite to form S-GrM hybrid-nanobiocomposite. The process parameters for fabrication of S-GrM hybrid-nanobiocomposite was optimized by RSM based on four responses of easy magnetic separation, biofilm formation along with protein, and carbohydrate contents in extracellular polymeric substances (EPS). The morphology and chemical composition of S-GrM hybrid-nanobiocomposite were investigated using various spectroscopic and microscopic analyses and subsequently explored for removal of Cr3+ ions. The hybrid-nanobiocomposite effectively removed 304.64 ± 14.02 mg/g of Cr3+ at pH 7.0 and 30 °C, which is found to be very high compared to the previously reported values. The high surface area of graphene, biofilm biomass of S. oneidensis and plenty of functional groups provided a unique structure to the S-GrM hybrid-nanobiocomposite for efficient removal of Cr3+ through synergistic interaction. The FTIR and zeta potential studies confirmed that electrostatic and chelation/complexation reaction played key roles in the adsorption process. The fabrication of S-GrM nanobiocomposite thus creates a novel hybrid 'living functional nanomaterial' for low cost, recyclable, and sustainable removal of Cr3+ from wastewater.

Biomolecule-assisted synthesis of biomimetic nanocomposite hydrogels reduces the environmental impact and has potential applications in hemostasis and wound healing.

Owing to the emergence of antibiotic-resistant strains, bacterial infection and biofilm formation are growing concerns in healthcare management. Herein, we report an eco-benign strategy for the synthesis and functionalization of graphene-silver (rGOAg) nanocomposites with an antimicrobial peptide (AMP) for the treatment of Staphylococcus aureus infection. The synthesis of rGOAg nanocomposites was carried out by simple microwave reduction, and the as-synthesized rGOAg was covalently functionalized with an AMP. As a natural AMP, poly-l-lysine (PLL) functionalization of rGOAg enhanced the antibacterial efficacy and target specificity against the S. aureus biofilm. The robust bactericidal efficiency and biofilm disruption by AMP-functionalized rGOAg (designated as GAAP) occurred through the "contact-kill-release" mode of action, where the electrostatic interaction with bacterial cells together with intracellular ROS generation induced physical disruption to the cell membrane. The internalization of GAAP into the cytoplasm through the damaged cell membrane caused an outburst of intracellular proteins and DNA. Crystal violet staining along with fluorescence and confocal microscopic images showed an effective inhibition and disruption of the S. aureus biofilm upon treatment with GAAP. PLL functionalization also prevented the dissolution of Ag+ ions and thereby minimized the in vitro toxicity of GAAP to the 3 T6 fibroblast and human red blood cells. The ex vivo rat skin disinfection model further demonstrated the potency of GAAP in eliminating the biofilm formation and disruption of the S. aureus biofilm. The obtained results demonstrated a general approach for designing a functional nanocomposite material to disrupt the mature biofilm and provided a promising strategy for treating bacterial infection.

Several approaches for elimination of oral pathogens are being explored at the present time since oral diseases remain prevalent affecting approximately 3.5 billion people worldwide. Need for antimicrobial biomaterials in dental healthcare include but is not restricted to designing resin composites and adhesives for prevention of dental caries. Constant efforts are also being made to develop antimicrobial strategies for clearance of endodontic space prior root canal treatment and for treatment of periimplantitis and periodontitis. This article discusses various conventional and nanotechnology-based strategies to achieve antimicrobial efficacy in dental biomaterials. Recent developments in the design and synthesis of antimicrobial peptides and antifouling zwitterionic polymers to effectively lessen the risks of antimicrobial drug resistance are also outlined in this review. Further, the role of contemporary strategies such as use of smart biomaterials, ionic solvent-based biomaterials and quorum quenchers incorporated biomaterials in the elimination of dental pathogens are described in detail. Lastly, we mentioned the approach of using polymers to print custom-made three-dimensional antibacterial dental products via additive manufacturing technologies. This review provides a critical perspective on the chemical, biomimetic, and engineering strategies intended for developing antimicrobial biomaterials that have the potential to substantially improve the dental health.

A Dansyl functionalized fluorescent probe (DFFP) has been intended, synthesized, and well-characterized (NMR, IR, Mass, SEM, SCXRD), capable of sensing trace amounts of water contaminant in hygroscopic deuterated solvents by changing colour under UV irradiation. A distinct bathochromic shift in emission spectra of probe DFFP and the visual colour change (Green to Yellow) under UV lamp are the key evidence of the presence of water contaminant. To prove the potentiality of the probe while detecting the remnant water, we did some experimental studies along with exhaustive theoretical evaluation. DFT (Energy optimization and other calculations) helped in better understanding the sensing mechanism and the mode of interactions among probe-water-solvent. Total electron density mapped over Electrostatic Potential Surface and calculation of ESP charges helped in locating more electron-dense regions in the ground state. The involvement of TD-DFT studies helped in finding the possible electronic transitions and corresponding absorption bands. Moreover, the probe is capable of sensing ethanolic water vapour in the gaseous phase. Due to high fluorescence and being nontoxic to cells, probe DFFP could be used as a potential cell imaging dye. It has been employed in a human cancer cell line (A549), and fluorescent confocal microscopic images were obtained.